UPDATED on Dec. 11, 2018 with photo from the Dec, 10, 2018 ceremony.
ORIGINAL STORY: James P. Allison, Ph.D., an immunologist at The University of Texas MD Anderson Cancer Center, is in Sweden to receive the 2018 Nobel Prize in Physiology or Medicine jointly with Japanese immunologist Tasuku Honjo, M.D., Ph.D.
The pair were announced on Oct. 1 as laureates for the discovery of cancer therapies that stimulate the immune system to attack tumor cells. Treatments developed from Allison’s work have extended the lives of thousands of people with advanced disease, though certain cancers have responded better to immunotherapy than others.
Allison delivered his Nobel lecture entitled “Immune Checkpoint Blockade in Cancer Therapy: New insights, opportunities, and prospects for cures” on Dec. 7 in Stockholm.
Both Allison, 70, and Honjo, 76, made discoveries that led to the development of “checkpoint inhibitors”—drugs infused into patients to block molecules that put the brakes on T cells. By releasing these brakes, the body’s own immune system is able to fight cancer.
Each scientist will receive a Nobel medal and diploma. They will also share a nearly $1 million prize.
According to MD Anderson, Allison has been busy during Nobel Week in Sweden. On Thursday, he signed the bottom of a chair at Bistro Nobel in the Nobel Museum in Stockholm’s Old Town. The ritual is part of a traditional museum visit by Nobel winners and launches the week’s events.
Laureates traditionally donate artifacts to the Nobel Museum. Allison presented the museum with the following items:
- A vial representing 9H10, a mouse-model monoclonal antibody developed in his lab in 1995 to block CTLA-4, a protein on T cells that shuts down immune response
- A vial of ipilimumab from Bristol-Myers Squibb that was developed for human use based on Allison’s work
- The first page of a 1996 article in Science that reported the success of anti-CTLA-4 treatment in freeing T cells to attack cancer in mice
- The first page of a 2015 review in Cell that was co-authored by Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology at MD Anderson, who is the scientist’s longtime research collaborator and spouse
- A portrait of Allison and Sharma taken by a Dallas photographer
Allison is the first Nobel laureate for MD Anderson, where he is a professor and chair of the department of immunology. He is the executive director of the Immunotherapy Platform, which is part of MD Anderson’s Moon Shots Program—an ambitious effort to more rapidly reduce cancer deaths and suffering by developing advances in prevention, early detection and treatment based on scientific discoveries. In addition, Allison holds the Vivian L. Smith Distinguished Chair in Immunology and serves as deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers in the department of genitourinary medical oncology.
Read more about Allison in this profile published in the November 2018 issue of TMC Pulse.
University of Houston@UHouston
RT @FrontierFiesta: 📸LIVE right now at #FrontierFiesta! https://t.co/PwwxUeSu3V
Today’s #VeteranOfTheDay is Marine Corps Veteran Brad Pesek. Brad served for 20 years and made multiple #OIF deployments https://t.co/JDJk73aIjb
University of Houston@UHouston
RT @MarchMadnessTV: Houston is on a mission to make the city proud.Kelvin Sampson has fostered a family atmosphere all around @UHCougarMB…
See how Melanie McNeal stays fit in this week's healthy habits post. https://t.co/YDURUq6Ii5 #healthy #habits
Baylor College of MedicineBaylorCollegeOfMedicine
For decades, the link between education and healthcare has been the driving concept behind development of programs to improve community health at Baylor College of Medicine. Learn more about our initiatives: https://bit.ly/2t4NynV #education #community
SECCA Presents Staged Reading of WWII Pacific Engagement Veterans’ Stories https://t.co/rFBKFyDPpc via @yesweekly
U.S. Department of Veterans AffairsVeteransAffairs
Happy Birthday, Frank!
Families with children of all abilities are invited to the annual Texas Children’s West Campus Family Fun Run on Saturday, April 6. Register your family at https://t.co/kj6xpuWTSJ
“People who carry hereditary mutations do not necessarily get cancer, but their risk of developing the disease at some point during their lifetime is higher than average,” says our @KarenLuMD.How we help those with genetic risk of #cancer: https://t.co/W6Rf3WPl9r #endcancer
MD Anderson Cancer CenterMDAnderson
"I was really worried about the recovery," recalls Bridgette Fleming, who underwent laparoscopic colon resection in late March 2018 to treat her colon cancer. "But I was surprised that even after a major abdominal surgery, I only had to use the pain pump twice a day for a few days."Here's how our Enhanced Recovery Program is helping patients like Bridgette rebound faster after surgery. #endcancer
Congratulations on another great event, @CathyEngMD, and thanks for all you do to help us #endcancer. https://t.co/tzg8ukTJuL
RT @wendyegriffith: #AYACancer Scholarship Program is open for @MDAndersonNews & @KidsAndCancer patients aged 16-29 seeking post-high schoo…
A candlelight vigil was held March 20 commemorating the 50 lives lost in the New Zealand mosque attacks.On March 27, Rice will host an Islamophobia teach-in all day in solidarity with the Muslim community: https://t.co/ugA11IDcGz https://t.co/8siFEZshmc
Inside Oneida County's fight to end Veteran homelessness https://t.co/0QosaHZPhl via @uticaOD
For decades, the link between education and healthcare has been the driving concept behind development of programs to improve community health at Baylor College of Medicine. Learn more about our initiatives: https://t.co/wtLRXl71w6 #education #community https://t.co/kyJoF4rIye